CompaniesTetra Bio-Pharma

Tetra Bio-Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

7

As Collaborator

1

Total Enrollment

761

By Phase

PHASE3: 2PHASE2: 4PHASE1: 2

By Status

TERMINATED: 3UNKNOWN: 2COMPLETED: 2SUSPENDED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT04042545
NCT04001010
Hover over trial bars to see details

Recent Trials

NCT04001010Lead Sponsor
Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia
PHASE3Suspended
334 participants
Started: Jul 31, 2022 · Completed: Dec 31, 2023
NCT03564548Lead Sponsor
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
PHASE2Unknown
20 participants
Started: May 26, 2021 · Completed: Apr 30, 2022
NCT04042545Lead Sponsor
Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer
PHASE2Unknown
78 participants
Started: Jul 30, 2020 · Completed: Sep 30, 2022
NCT04461756Lead Sponsor
Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
PHASE1Completed
12 participants
Started: Nov 1, 2018 · Completed: Nov 24, 2018
NCT03339622Lead Sponsor
Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients
PHASE3Terminated
8 participants
Started: Mar 29, 2018 · Completed: Feb 8, 2019
View all 8 trials →
Funding History (1)
D
Jun 12, 2020
Filing